Low-dose Digital Radiographs in the Idiopathic Scoliosis
Repeatability and Reproducibility of Low-dose Digital Radiographs in the Idiopathic Scoliosis
1 other identifier
observational
105
1 country
1
Brief Summary
The aim of the study is to evaluate the intraobserver repeatability and the interobserver reproducibility of low-dose radiographs with a HELIOS DRF (CAT) imaging system in patients with idiopathic scoliosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 27, 2018
CompletedFirst Submitted
Initial submission to the registry
March 7, 2018
CompletedFirst Posted
Study publicly available on registry
March 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedSeptember 26, 2023
September 1, 2023
1.9 years
March 7, 2018
September 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Repeatability and reproducibility
Repeatability and reproducibility of the Cobb angle measurement
baseline (day 0)
Secondary Outcomes (2)
Repeatability and reproducibility
baseline (day 0)
Radiation exposure
baseline (day 0)
Eligibility Criteria
patients with suspected or known idiopathic scoliosis selected at the Rizzoli Orthopaedic Institute
You may qualify if:
- patients with suspected or known idiopathic scoliosis
- patients able to maintain orthostasis without medical devices
- patients from 9 to 20 years old
You may not qualify if:
- patients with known congenital, syndromic, neurological scoliosis
- patients not able to maintain orthostasis
- obese patients
- low back pain or known tumor pathology
- patients with vertebral arthrodesis
- patients younger than 9 years old, or older than 20 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rizzoli Orthopaedic Institute
Bologna, 40136, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Milva Battaglia, MD
Rizzoli Orthopaedic Institute
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2018
First Posted
March 14, 2018
Study Start
January 27, 2018
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
September 26, 2023
Record last verified: 2023-09